Cardea's BPU™ (Biosignal Processing Unit) is a biocompatible semiconductor capable of translating real-time streams of multiomics signals to digital information
Have you started following @Paragraf_Gr yet? Don't miss out on future news about Cardea, now part of Paragraf. This page will soon be inactive - follow us now:
https://t.co/f1FxeJO3nz
https://t.co/jltB9aby0L
https://t.co/UICSKXAXDF
Have you checked out our Knowledge Centre, with topics such as #quantumcomputing, #EVbatteries and #biosensors. Now that Cardea has joined Paragraf, this LinkedIn page will be inactive. Don't miss out on new content - follow @Paragraf_Gr .
https://t.co/rq2s5KJWBk
Cardea Bio has joined forces with Paragraf, combining expertise in #graphene electronics and life science applications. We are thrilled to embark on this shared journey & will soon close this account. Continue to stay updated on our news, follow Paragraf® https://t.co/ogOQZhPFLk
The acquisition of Cardea Bio will enable Paragraf to offer a new generation of biosensing devices. As we grow together as a company, we will be closing this account. Stay up to date with Cardea Bio and Paragraf news, follow us at @Paragraf_Gr.
https://t.co/zj4Y9VuW4A
In May, Cardea Bio became part of Paragraf, transforming #graphene device manufacturing with its pioneering scalable approach. We are excited to continue our journey together. Stay informed about Cardea Bio and Paragraf news by following us at @Paragraf.
https://t.co/XZT8cNfigO
Researchers from @KeckMedUSC and @CardeaBio, which @Paragraf_Gr acquired in May 2023, demonstrate simultaneous detection of SARS-CoV-2 RNA and protein. https://t.co/buc71UJsjg @GENbio
"We're taking significant leaps forward! With drastically increased bandwidth in terms of graphene-based biosensor production, but also being able to significantly reduce the time to developing the next generations of BPUs." - states Dr. @kiana_aran
More https://t.co/rZnLgcaql3
Novel multiomics methodology enables detection of both protein and RNA or DNA biosignals simultaneously on a single graphene-based biosensor:
https://t.co/puDDHpx88I #multiomics#CRISPR#graphene#biosensor#BPU
The acquisition of @CardeaBio will enable Paragraf to accelerate mass production of #nextgen devices that will deliver real-time analysis in point-of-need tests in agri-tech, healthcare and environmental monitoring spaces:
https://t.co/kJ3LIUZjZs
#graphene#biosensors
“It's not common for scientists to have their tech featured in a museum, so to see my CRISPR-chip next to Watson and Crick's DNA model is a proud moment in my career!” states @kiana_aran
Ful story:
https://t.co/x6IGkzvjNc #crispr#crisprchip#dhmd#dresden#kianaaran
We're immensely proud that the startup community is acknowledging and supporting our CSO, Dr. @kiana_aran’s tremendous achievements - today she made Inc.'s official 2023 list of Female Founders:
https://t.co/Vl0Y3m7wai #femalefounders
Senior Scientist at @NIST, Dr. @HightWalker, continues: “Graphene will play a major role in multiple industries; developing documentary standards will certainly hasten the pace. Leadership by U.S. industry in developing standards is critical for emerging technologies.”
"We see a bright future for diagnostic tools based on graphene electronics, but we’re not waiting for that future - we’re making it happen! That means driving reliability and predictability in the graphene material industry." ~ states Brett Goldsmith https://t.co/hYWmz6upkk
Graphene has outperformed silicon as one of the most biocompatible tools for biological innovation. This episode of @BioITWorld Trends from the Trenches @StanGloss and Dr. @kiana_aran discuss the strengths of #graphene and its future in biotech. Listen now https://t.co/LFH10LXSyS